Rebecca Letterer

The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)

Jackson T. Wright, William C. Cushman, Barry R. Davis et al. · Controlled Clinical Trials · 2001 · 311 citations

Hypertension, Lipid-lowering Treatment, Health Policy +10

Effect of pravastatin on cardiovascular events in women after myocardial infarction: the Cholesterol and Recurrent Events (CARE) trial

Sandra Lewis, Frank M. Sacks, Jayne S. Mitchell et al. · Journal of the American College of Cardiology · 1998 · 235 citations

Thrombosis, Cardiovascular Events, Cardiovascular Disease +8

The HOPE (Heart Outcomes Prevention Evaluation) Study: The design of a large, simple randomized trial of an angiotensin converting enzyme inhibitor (ramipril) and vitamin E in patients at high risk of cardiovascular events

F Mindlen, Roberto Nordaby, M I Soto Ruiz et al. · Queensland's institutional digital repository (The University of Queensland) · 1996 · 154 citations

Non-pharmacological Intervention, Preventive Medicine, Cardiovascular Disease +10

Hemodynamic Effects of the Angiotensin-Converting Enzyme Inhibitor, Ramipril, in Patients with Mild to Moderate Aortic Stenosis and Preserved Left Ventricular Function

Kevin D. O’Brien, Xue-Qiao Zhao, David M. Shavelle et al. · Journal of Investigative Medicine · 2004 · 93 citations

The Effects of Atorvastatin (10 mg) on Systemic Inflammation in Heart Failure

Dariush Mozaffarian, Elina Minami, Rebecca Letterer et al. · The American Journal of Cardiology · 2005 · 67 citations

Inflammation, Heart Failure, Cardiovascular Disease +8